Ciprofloxacin pp 19-21 | Cite as
The Activity of Ciprofloxacin and Other 4-Quinolones Against Chlamydia trachomatis and Mycoplasmas In Vitro
Chapter
Abstract
Ciprofloxacin was found to be the most active of a group of 4-quinolone antibiotics tested against the SA2 f strain of Chlamydia trachomatis (MBC and MIC 1.0 mg/l). Against genital isolates of Chlamydia trachomatis, ciprofloxacin was twice as active as rosoxacin. Ciprofloxacin showed similar activity to that of oxytetracycline against clinical isolates of Mycoplasma hominis and Ureaplasma urealyticum, and was 8-fold more active than rosoxacin against the latter.
Preview
Unable to display preview. Download preview PDF.
References
- 1.Felmingham, D., O’Hare, M. D., Grüneberg, R. N., Ridgway, G. L.: The comparative activity of eleven quinolone antibiotics against penicillin-sensitive, penicillin-resistant non beta-lactamase producing and beta-lactamase producing isolates of N. gonorrhoeae. In: Spitzy, K. H., Karrer, K. (ed.): Proceedings of the 13th International Congress of Chemotherapy. H. Egermann, Vienna, 1983, 112, p. 27–30.Google Scholar
- 2.Ridgway, G. L., Owen, J. M., Oriel, J. D.: A method for testing the antimicrobial sensitivity of Chlamydia trachomatis in a cell culture system. Journal of Antimicrobial Chemotherapy 1976, 2: 77–81.CrossRefGoogle Scholar
- 3.Ridgway, G. L., Owen, J. M., Oriel, J. D.: The antimicrobial susceptibility of Chlamydia trachomatis in cell culture. British Journal of Venereal Diseases 1978, 54: 103–106.PubMedGoogle Scholar
- 4.Taylor-Robinson, D.: Mycoplasmas of various hosts, and their antibiotic sensitivities. Postgraduate Medical Journal 1967, 43, Supplement: 100–104.PubMedGoogle Scholar
- 5.Evans, R. T., Taylor-Robinson, D.: The incidence of tetracycline resistant strains of Ureaplasma urealyticum. Journal of Antimicrobial Chemotherapy 1978, 4: 57–63.PubMedCrossRefGoogle Scholar
- 6.Oriel, J. D., Ridgway, G. L.: Genital Infection by Chlamydia trachomatis. Edward Arnold, London, 1982, p. 86–98.Google Scholar
- 7.Meier-Ewert, H., Weil, G., Millott, G.: In vitro activity of norfloxacin against Chlamydia trachomatis. European Journal of Clinical Microbiology 1983, 2: 271–272.PubMedCrossRefGoogle Scholar
- 8.Eandi, M., Viano, I., Di Nola, F., Leone, L., Genazzani, E.: Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage. European Journal of Clinical Microbiology 1983, 2: 253–259.PubMedCrossRefGoogle Scholar
- 9.Crump, B., Wise, R., Dent, J.: Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1983, 24: 784–786.PubMedCrossRefGoogle Scholar
Copyright information
© Springer Fachmedien Wiesbaden 1986